Search

Your search keyword '"Ducrocq G"' showing total 333 results

Search Constraints

Start Over You searched for: Author "Ducrocq G" Remove constraint Author: "Ducrocq G"
333 results on '"Ducrocq G"'

Search Results

4. Incidence and predictors of in-hospital complications after myocardial infraction in contemporary clinical practice: Findings from the FRENCHIE myocardial infarction cohort

5. Ticagrelor versus clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome: A post-hoc analysis of the ALPHEUS study

9. Impact of transfusion on platelet aggregation and biomarkers in myocardial infarction patients with anemia: an ancillary study of the randomized REALITY trial

11. Effect of a restrictive vs. liberal blood transfusion strategy among patients with acute myocardial infarction and anemia according to heart failure. A subgroup analysis of the REALITY trial

19. Interobserver variability in the classification of congenital coronary abnormalities: A substudy of the anomalous connections of the coronary arteries registry

25. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

28. Physiological Evaluation of Anomalous Aortic Origin of a Coronary Artery Using Computed Tomography–Derived Fractional Flow Reserve

29. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

34. Transseptal transcatheter mitral valve implantation versus redo surgical mitral valve replacement for degenerated mitral bioprostheses

39. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

40. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

41. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

46. P1694Sex is not an independent predictor of ischemic outcomes or bleeding in NSTEMI patients undergoing percutaneous coronary intervention. Insights from the TAO trial

48. Identifying higher risk patients among the COMPASS-Eligible population: An analysis from the REduction of Atherothrombosis for Continued Health (REACH) Registry

49. P5106Prevalence, clinical characteristics and outcomes of procedural complications of percutaneous coronary intervention in non ST-elevation myocardial infarction: insights from the TAO trial

Catalog

Books, media, physical & digital resources